🇺🇸 FDA
Pipeline program

-, -, CIMETIDINE , ROXATIDINE , FAMOTIDINE, COMBINATIONS, PARACETAMOL , RANITIDINE , NIZATIDINE , SKB264, FAMOTIDINE , -

KL264-01

Phase 2 small_molecule active

Quick answer

-, -, CIMETIDINE , ROXATIDINE , FAMOTIDINE, COMBINATIONS, PARACETAMOL , RANITIDINE , NIZATIDINE , SKB264, FAMOTIDINE , - for Metastatic or locally advanced unresectable solid tumors progressing after available standard therapies is a Phase 2 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Pharma Mar S.A.
Indication
Metastatic or locally advanced unresectable solid tumors progressing after available standard therapies
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials